InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by MAHONEY DAVID L. Officer active across 3 companies, notably Corcept Therapeutics INC. Aggregated, 8 disclosures have been logged. The latest transaction was filed on 27 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€113,20330,000 shares@ €3.77340.0019% mcap34.1% of flow
Common Stock
SEC:0000899243-22-020211:0·
€109,18530,000 shares@ €3.63950.0018% mcap32.9% of flow
Common Stock
SEC:0000899243-22-011615:0·
5,000 shares
Common Stock
SEC:0001328143-21-000094:0·
5,000 shares
Common Stock
SEC:0001328143-21-000094·
05,000 shares0
Common Stock
SEC:0001328143-21-000059·
05,000 shares0
Common Stock
SEC:0001328143-21-000059:0·
€109,18530,000 shares@ €3.63950.0030% mcap100.0% of flow
Common Stock
SEC:0000899243-21-019425·
€109,18530,000 shares@ €3.63950.0018% mcap32.9% of flow
Common Stock
SEC:0000899243-21-019425:0·
8 of 8 declarations
About MAHONEY DAVID L
David L Mahoney is a director at Corcept Therapeutics INC and has also filed at Adamas Pharmaceuticals Inc and CORCEPT THERAPEUTICS INC.
